RASGRF1 and pancreatic ductal adenocarcinoma: We and others recently reported a distinct class of oncogenic fusions involving the RAS-GEF RASGRF1 in NSCLC, pancreatic ductal adenocarcinoma (PDAC), melanoma, and sarcoma19–21.